secwatch.observer — SEC 8-K summary
======================================

Issuer:     Beam Therapeutics Inc. (BEAM)
CIK:        0001745999
Form:       8-K
Filed at:   2024-06-10T23:59:59+00:00
Accession:  0000950170-24-071345
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Beam Therapeutics shareholders elect Graham Cooper as Class I director, ratify auditor, approve say-on-pay
--------------------------------------------------------------------------------

- Graham Cooper elected to board with 49.5M for, 6.5M against, 1.8M abstain, 8.4M broker non-votes.
- Deloitte & Touche ratified as auditor for FY2024: 66.0M for, 176k against, 42k abstain.
- Advisory vote on executive compensation passed: 56.5M for, 1.3M against, 45k abstain, 8.4M broker non-votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1745999/000095017024071345/0000950170-24-071345-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1745999/000095017024071345/beam-20240605.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-071345

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer